Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  British Journal of Ophthalmology

• Publication date

  1996-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjo.80.2.159PMID 8814748PMCID PMC505409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

  2005cited by this paper
• Angiotensin levels in the eye.

  1994cited by this paper
• Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.

  1993cited by this paper
• An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen.

  1992cited by this paper
• The Tissue Renin-Angiotensin Systems in Cardiovascular Disease

  1992cited by this paper
• The tissue renin-angiotensin systems in cardiovascular disease.

  1992cited by this paper
• Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall.

  1991cited by this paper
• Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.

  1991cited by this paper
• Identification and quantification of renin and prorenin in the bovine eye.

  1990cited by this paper
• High plasma prorenin in diabetes mellitus and its correlation with some complications.

  1990cited by this paper
• Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

  1989cited by this paper
• Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.

  1989cited by this paper
• Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma.

  1988cited by this paper
• Angiotensin-converting enzyme in bovine, feline, and human ocular tissues.

  1988cited by this paper
• Angiotensinogen gene expression in neuronal and glial cells in primary cultures of rat brain

  1988cited by this paper
• Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

  1988cited by this paper
• Ocular renin-angiotensin: immunohistochemical evidence for the presence of prorenin in eye tissue.

  1988cited by this paper
• Renin in glioblastoma multiforme and its role in neovascularization.

  1988cited by this paper
• Circulating and tissue angiotensin systems.

  1987cited by this paper
• Angiotensin binding sites in bovine and human retinal blood vessels.

  1987cited by this paper
• The response of retinal vasculature to angiotensin.

  1987cited by this paper
• Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography.

  1987cited by this paper
• Presence of renin in primary neuronal and glial cells from rat brain.

  1987cited by this paper
• Circulating and Tissue Angiotensin Systems

  1987cited by this paper
• The Effects of Indecainide, a New Antidysrhythmic Drug, on Nodal Tissues in the Isolated Rabbit Heart

  1986cited by this paper
• Regulation of tissue renin and angiotensin gene expressions.

  1986cited by this paper
• Localization of renin (EC 3.4.23) and converting enzyme (EC 3.4.15.1) in nerve endings of rat brain.

  1985cited by this paper
• Angiotensin-converting enzyme activity in human aqueous humor.

  1985cited by this paper
• Neovascularization produced by angiotensin II.

  1985cited by this paper
• Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications.

  1985cited by this paper
• Early breakdown of the blood-retinal barrier in diabetes.

  1975cited by this paper

• Repurposing Renin–Angiotensin System Drugs for the Treatment of Audiovestibular Disorders

  2026cites this paper
• Ythdf2 loss in microglia aggravates ischemic retinopathy by increasing microglia activation and microvascular anomalies.

  2025cites this paper
• Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review

  2025cites this paper
• Angiotensin II and angiotensin converting enzyme: key players in the pathogenesis of hypertensive retinopathy

  2025cites this paper
• Long-term retinal oximetry and OCT angiography in patients recovered from COVID-19

  2025cites this paper
• Revisiting the renin-angiotensin-aldosterone system in the eye: mechanistic insights and pharmacological targets.

  2025cites this paper
• Glaucoma and the ocular renin-angiotensin-aldosterone system: Update on molecular signalling and treatment perspectives.

  2024cites this paper
• Decrease of Prolylcarboxypeptidase Dose of Aqueous Humor is Involved in the Pathogenesis of Primary Open-Angle Glaucoma via Finetuning of the Local Ocular Renin-Angiotensin System

  2024cites this paper
• N-Methyl-d-Aspartate-Induced Excitotoxicity and Its Impact on the Renin–Angiotensin System in Retinal Tissue

  2024cites this paper
• Impacts of angiotensin II on retinal artery changes in apolipoprotein E deficient mice.

  2024cites this paper
• Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy

  2023cites this paper
• Identifying novel candidate compounds for therapeutic strategies in retinopathy of prematurity via computational drug-gene association analysis

  2023cites this paper
• Glucose transport, transporters and metabolism in diabetic retinopathy.

  2023cites this paper
• Elevated Angiotensin-II Levels Contribute to the Pathogenesis of Open-Angle Glaucoma Via Inducing the Expression of Fibrosis-Related Genes in Trabecular Meshwork Cells Through a ROS/NOX4/SMAD3 Axis

  2023cites this paper
• Investigation of changes in retinal vascular parameters and choroidal vascular index values during the early recovery period of COVID-19: The COVID-OCTA study

  2023cites this paper
• The systemic angiotensin-II role in the development of retinopathy of prematurity

  2023cites this paper
• Manifestaciones oftálmicas en pacientes recuperados de COVID-19 en México

  2023cites this paper
• Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.

  2023cites this paper
• Internalization of Angiotensin-(1–12) in Adult Retinal Pigment Epithelial-19 Cells

  2023cites this paper
• Angiotensin II-Related Activation of Scleral Fibroblasts and Their Role on Retinal Ganglion Cell Death in Glaucoma

  2023cites this paper
• Angiotensin II-related activation of scleral �broblasts and the role of retinal ganglion cell death in glaucoma

  2023cites this paper
• Ophthalmic manifestations in patients recovered from COVID-19 in Mexico

  2023influential citation
• Investigation of Changes in Retinal Vascular Parameters and Choroidal Vascular Index Values During The Early Recovery Period of COVID-19: The COVID-OCTA Study

  2023cites this paper
• The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma

  2022cites this paper
• Ocular Distribution of the Renin-Angiotensin-Aldosterone System in the Context of the SARS-CoV-2 Pandemic

  2022cites this paper
• Central serous chorioretinopathy in coronavirus disease-19 patient

  2022cites this paper
• Unilateral Acute Idiopathic Maculopathy following Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) Infection

  2022cites this paper
• Differential distribution of steroid hormone signaling networks in the human choroid-retinal pigment epithelial complex

  2022cites this paper
• Evaluation of Retinal Microvascular Impairment after COVID-19 and its Clinical Correlates Using Optical Coherence Tomography Angiography

  2022cites this paper
• Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B virus, and SARS-CoV-2

  2022cites this paper
• Endocrine Dysfunction in Open Angle Glaucoma Endokrine Auffälligkeiten beim Offenwinkelglaukom

  2021cites this paper
• Symptoms in healthcare professionals infected with SARS-CoV-2 at a university hospital

  2021cites this paper
• SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease

  2021cites this paper
• Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19

  2021cites this paper
• Histopathological assessments reveal retinal vascular changes, inflammation and gliosis in patients with lethal COVID-19

  2021cites this paper
• Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography

  2021cites this paper
• Ophthalmic manifestations in the COVID-19 clinical spectrum

  2021cites this paper
• COVID-19: More than a Respiratory Virus, An Optical Coherence Tomography Study

  2021cites this paper
• COVID-19: more than a respiratory virus, an optical coherence tomography study

  2021cites this paper
• Local Renin-Angiotensin System Activation and Myofibroblast Formation in Graft Versus Host Disease–Associated Conjunctival Fibrosis

  2021cites this paper
• Combined endophthalmitis and orbital cellulitis in patients with corona virus disease (COVID-19)

  2021cites this paper
• Potency of SARS-CoV-2 on Ocular Tissues

  2021cites this paper
• Renin-Angiotensin System Inhibitor Usage and Age-Related Macular Degeneration among Hypertensive Patients: Results from the National Health and Nutrition Examination Survey, 2005–2008

  2020cites this paper
• Retinal changes in COVID-19 hospitalized cases

  2020cites this paper
• Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease

  2020cites this paper
• Ocular findings and risk of transmission in patients with Covid-19 infection

  2020cites this paper
• ISOLATION OF NOVEL CORONAVIRUS IN TEARS AND CONJUNCTIVAL SECRETIONS FROM COVID-19 PATIENTS PRESENTING WITH KERATOCONJUNTIVITIS

  2020cites this paper
• Angiotensin-II as a Trigger Factor in the Development of Retinopathy of Prematurity

  2020cites this paper
• Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV

  2020cites this paper
• Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review

  2020cites this paper
• Ocular Surface Expression of SARS-CoV-2 Receptors

  2020cites this paper
• Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)

  2020cites this paper
• COVID-19 and ocular implications: an update

  2020cites this paper
• Coronavirus disease in ophthalmology practice: Current scenario; available evidence; and its implications

  2020cites this paper
• Extra-respiratory manifestations of COVID-19

  2020cites this paper
• Angiotensin-(1–7) Attenuates Protein O-GlcNAcylation in the Retina by EPAC/Rap1-Dependent Inhibition of O-GlcNAc Transferase

  2020cites this paper
• Absence of Severe Acute Respiratory Syndrome-Coronavirus-2 RNA in Human Corneal Tissues

  2020cites this paper
• Preeclampsia as predisposing factor for hypertensive retinopathy: Participation by the RAAS and angiogenic factors.

  2020cites this paper
• Ангиотензин-II как пусковой фактор развития ретинопатии недоношенных

  2020cites this paper
• Beyond the lung involvement in COVID-19 patients. A review.

  2020cites this paper
• Therapeutic effects of various renin angiotensin modulators on hyperglycemia-induced cataract formation in Sprague Dawley rats

  2020cites this paper
• The renin-angiotensin system and the retinal neurovascular unit: A role in vascular regulation and disease.

  2019cites this paper
• Angiotensin II and aldosterone in retinal vasculopathy and inflammation.

  2019cites this paper
• [The effect of intravitreally administered angiogenesis inhibitor on the concentration of angiotensin-converting enzyme in the blood serum and lacrimal fluid in patients with diabetic macular edema].

  2019cites this paper
• Losartan delays the progression of streptozotocin‐induced diabetic cataracts in albino rats

  2019cites this paper
• The renin angiotensin aldosterone system and its therapeutic targets.

  2019cites this paper
• Systemic ß adrenergic stimulation/ sympathetic nerve system stimulation influences intraocular RAS through cAMP in the RPE.

  2019cites this paper
• Inhibitory effect of Telmisartan on STZ-induced early retinopathy in diabetic mice

  2019cites this paper
• Control of the retinal local RAS by the RPE: An interface to systemic RAS activity.

  2019cites this paper
• Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival

  2018cites this paper
• Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy

  2018cites this paper
• Antihypertensive tripeptides and vasculature. Focus on mechanisms, ageing, cis/trans-stereoisomers and intestinal permeability

  2018cites this paper
• Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture

  2018cites this paper
• Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression

  2018influential citation
• Four decades of ocular renin‐angiotensin and kallikrein‐kinin systems (1977–2017)

  2018cites this paper
• Utility of angiotensin-converting enzyme activity in aqueous humor in the diagnosis of ocular sarcoidosis

  2017cites this paper
• The Relationship Between the Renin-Angiotensin-Aldosterone System and NMDA Receptor-Mediated Signal and the Prevention of Retinal Ganglion Cell Death.

  2017cites this paper
• The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) –induced VEGF expression in ARPE-19 cells under a hyperglycemic condition

  2017cites this paper
• Mechanisms of Vascular Defects in Diabetes Mellitus

  2017influential citation
• Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.

  2017cites this paper
• Pathogenetic Mechanisms in Diabetic Retinopathy: From Molecules to Cells to Tissues

  2017cites this paper
• Pharmacology of the retinal pigment epithelium, the interface between retina and body system.

  2016cites this paper
• Ototoxic effects and mechanisms of loop diuretics

  2016cites this paper
• Therapeutic targets of renin-angiotensin system in ocular disorders

  2016cites this paper
• Is there any association between primary hyperparathyroidism and ocular changes, such as central corneal thickness, retinal thickness, and intraocular pressure?

  2016cites this paper
• Involvement of Renin-Angiotensin System in Retinopathy of Prematurity - A Possible Target for Therapeutic Intervention

  2016cites this paper
• Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.

  2016cites this paper
• ARCHIVOS DE LA SOCIEDAD ESPAÑOLA DE OFTALMOLOGÍA

  2016influential citation
• EFFECT OF SYSTEMIC BETA-BLOCKERS, ACE INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS ON DEVELOPMENT OF CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION

  2015cites this paper
• Advanced Glycation End Products and Retinal Vascular Lesions in Diabetes Mellitus

  2015cites this paper
• Novel Potential Treatment Modalities for Ocular Hypertension: Focus on Angiotensin and Bradykinin System Axes

  2015cites this paper
• The Relationship Between Proteinuria and Urinary Angiotensinogen Levels in Patients with Nephrotic Syndrome Nefrotik Sendromlu Hastalarda Proteinüri ve İdrar Anjiyotensinojen Düzeyleri Arasindaki İlişki

  2015cites this paper
• Angiotensin II as a morphogenic cytokine stimulating fibrogenesis of human tenon's capsule fibroblasts.

  2015cites this paper
• Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model

  2015cites this paper
• The expression of Mas-receptor of the renin–angiotensin system in the human eye

  2015cites this paper
• Discovery of novel inhibitors for the treatment of glaucoma

  2015cites this paper
• Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats

  2015cites this paper
• Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina

  2015cites this paper
• The Relationship Between Proteinuria and Urinary Angiotensinogen Levels in Patients with Nephrotic Syndrome

  2015cites this paper
• Expression of classical components of the renin-angiotensin system in the human eye

  2015cites this paper